S-8510

A benzodiazepine inverse agonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

S-8510 on DrugBank
S-8510 on PubChem

1629; 2-(Isoxazol-3-yl)-1,6,7,9-tetrahydroimidazo[4,5-d]pyrano[4,3-b]pyridine

Link	Tested on	Impact factor	Notes	Publication date
Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein – Human ACE2 interface Spike protein ACE2 Small molecule In silico	in silico	2.46	Predicted to block the SARS-CoV-2 Spike protein-host ACE2 receptor interaction when combined with (2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one.	Feb/08/2021

Link	Publication date
Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients	Dec/31/2021
Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein - Human ACE2 interface.	Feb/08/2021
Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications - A pilot study	Feb/02/2021